We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

2 hedge funds and large institutions have $69K invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1512 (-149)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 148

100% less funds holding in top 10

Funds holding in top 10: 140 (-14)

100% less capital invested

Capital invested by funds: $2.42B → $69K (-$2.42B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-149
Holders Change %
-98.68%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
1
Closed
148
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Ninety One (UK)
1
Ninety One (UK)
United Kingdom
$67K -$103M -2,299,982 -100%
CCS
2
Crosspoint Capital Strategies
California
$2K +$2.83K +63 New
Schroder Investment Management Group
3
Schroder Investment Management Group
United Kingdom
-$273M -6,323,070 Closed
Wellington Management Group
4
Wellington Management Group
Massachusetts
-$229M -5,303,724 Closed
O
5
OppenheimerFunds
New York
-$171M -3,952,017 Closed
Fidelity International
6
Fidelity International
Bermuda
-$148M -3,429,038 Closed
MICM
7
Matthews International Capital Management
California
-$116M -2,694,589 Closed
TCA
8
Taconic Capital Advisors
New York
-$92.9M -2,150,000 Closed
PRCM
9
Pine River Capital Management
Minnesota
-$88.1M -2,039,192 Closed
ACM
10
Apex Capital Management
Ohio
-$74.5M -1,723,714 Closed
SC
11
Sculptor Capital
New York
-$74M -1,713,645 Closed
Jennison Associates
12
Jennison Associates
New York
-$71M -1,644,155 Closed
AAM
13
Alpine Associates Management
Florida
-$56.6M -1,309,111 Closed
FCM
14
Farallon Capital Management
California
-$55.9M -1,294,115 Closed
HIM
15
Hillhouse Investment Management
Cayman Islands
-$50.9M -1,177,079 Closed
Fidelity Investments
16
Fidelity Investments
Massachusetts
-$47.2M -1,092,700 Closed
BG
17
BlackRock Group
United Kingdom
-$45.9M -1,061,509 Closed
WHG
18
Westwood Holdings Group
Texas
-$38.7M -896,675 Closed
CBOA
19
Commonwealth Bank of Australia
Australia
-$32.9M -761,636 Closed
NA
20
Newport Asia
California
-$30.9M -714,600 Closed
GP
21
GLG Partners
United Kingdom
-$29.7M -687,093 Closed
Brown Advisory
22
Brown Advisory
Maryland
-$25.4M -586,907 Closed
CWAM
23
Columbia Wanger Asset Management
Illinois
-$25M -578,000 Closed
Bank of America
24
Bank of America
North Carolina
-$24.5M -567,730 Closed
SI
25
Sensato Investors
California
-$23.7M -549,341 Closed

WX Hedge Fund Activity: Q4 2015 in Review

2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q4 2015, worth a combined $69K — down 100% from $2.42B a quarter earlier.

Sellers outnumbered buyers: 148 funds closed out of WX and 1 opened new positions — a net loss of 147 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Crosspoint Capital Strategies, opening a new position worth an estimated $2.83K. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $273M sold.

  • 2 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q4 2015, down from 151 in Q3 2015.
  • Funds reported $69K of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q4 2015, down 100% quarter-over-quarter.
  • 1 fund opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q4 2015 and 148 closed out, a net change of -147 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q4 2015 was Crosspoint Capital Strategies, an estimated $2.83K added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q4 2015 was Schroder Investment Management Group, an estimated $273M sold.

Based on aggregated 13F filings for Q4 2015.